New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
06:53 EDTKBIOKaloBios downgraded to Hold from Buy at Needham
Needham downgraded KaloBios following the announcement that KB003 Ph II trial in severe asthma missed the primary endpoint of change in FEV1.
News For KBIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for KBIO

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use